GMOEX Performance — GMO Emerging Markets Fund, Class III
Data updated: 2026-09-29
GMOEX returned +39.09% year to date and +69.79% over one year to May 2026. Over one year the fund beat its Emerging Markets Equity category average: $100 grew to $170, against $149 for the category. Volatility over the past 12 months was 25.26% a year. In the 12 months to May 2026 the fund lost a net $66.4M, and assets reached $587.40M.
GMOEX Growth of $100
What $100 invested in GMO Emerging Markets Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | GMOEX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $170 | $149 |
| 3 years (Jun 2023 – May 2026) | $225 | $186 |
| 5 years (Jun 2021 – May 2026) | $144 | $145 |
| Since data start (Sep 2019 – May 2026) | $192 | $202 |
GMOEX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +39.09% |
| 1 year | +69.79% |
3- and 5-year figures withheld: cannot be verified.
GMOEX Annual Returns
Calendar-year total returns of GMO Emerging Markets Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +39.09% |
| 2025 | +33.82% |
| 2024 | +3.40% |
| 2023 | +17.63% |
| 2022 | −31.58% |
| 2021 | +2.02% |
| 2020 | +5.54% |
| 2019 (Sep–Dec) | +15.37% |
GMOEX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +9.9% | +7.0% | −10.5% | +9.8% | +20.3% | — | — | — | — | — | — | — |
| 2025 | +1.6% | −0.8% | +2.3% | +0.4% | +5.9% | +5.6% | +2.4% | +3.5% | +3.8% | +3.3% | −1.3% | +3.1% |
| 2024 | −2.1% | +3.4% | +0.7% | +1.1% | +2.3% | +0.5% | −0.3% | +1.8% | +3.7% | −4.3% | −1.6% | −1.5% |
| 2023 | +8.9% | −7.0% | +1.7% | +0.4% | −2.6% | +3.4% | +6.5% | −6.0% | −0.2% | −2.2% | +8.8% | +6.2% |
| 2022 | −1.5% | −11.3% | −7.8% | −5.7% | +1.6% | −6.4% | −1.6% | −0.7% | −11.6% | −0.6% | +14.7% | −3.9% |
| 2021 | +3.0% | +1.9% | +0.9% | +0.9% | +2.9% | −1.4% | −4.1% | +2.5% | −4.0% | +1.1% | −4.9% | +3.6% |
| 2020 | −6.6% | −4.3% | −15.3% | +8.7% | +1.9% | +4.6% | +6.5% | +0.6% | −2.7% | +0.4% | +8.8% | +5.6% |
| 2019 | — | — | — | — | — | — | — | — | +3.1% | +3.7% | +0.3% | +7.6% |
GMOEX Risk
Risk measures from monthly returns over Jun 2025 – May 2026.
- 1-year volatility (annualised): 25.26%
- Best month: +20.34% (May 2026)
- Worst month: −10.55% (Mar 2026)
GMOEX Fund Flows
Monthly money in and out of GMO Emerging Markets Fund, from SEC Form N-PORT.
- 12-month net flow: −$66.4M
- 12-month gross sales (incl. reinvestments): $116.8M
- Sales ÷ redemptions: 0.64×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $1.4M | $42.8M | −$41.5M |
| Apr 2026 | $61.1M | $64.6M | −$3.5M |
| Mar 2026 | $12.8M | $6.4M | $6.4M |
| Feb 2026 | $1.2M | $26.4M | −$25.2M |
| Jan 2026 | $5.1M | $2.1M | $3.0M |
| Dec 2025 | $23.7M | $2.7M | $21.0M |
| Nov 2025 | $3.4M | $3.3M | $85K |
| Oct 2025 | $388K | $12.6M | −$12.3M |
| Sep 2025 | $418K | $4.9M | −$4.4M |
| Aug 2025 | $5.0M | $4.6M | $438K |
| Jul 2025 | $1.3M | $5.2M | −$3.8M |
| Jun 2025 | $1.0M | $7.7M | −$6.7M |
GMOEX Assets Under Management
Net assets of GMO Emerging Markets Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $587.40M |
| 2026-02-28 | $530.11M |
| 2025-11-30 | $457.01M |
| 2025-08-31 | $447.75M |
| 2025-05-31 | $410.65M |
| 2025-02-28 | $370.55M |
| 2024-11-30 | $374.59M |
| 2024-08-31 | $401.91M |
| 2024-05-31 | $402.29M |
| 2024-02-29 | $458.38M |
| 2023-11-30 | $526.01M |
| 2023-08-31 | $708.05M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.